Redeye: Mr Green - A record year in the making
MRG presented yet another solid quarter with both net sales and profits almost spot-on our projections. The marketing push during Q2 seems to have, as we thought it would, paid off and the company grew their revenue organically by 27.8% in local currencies. We believe that MRG will end the year in high fashion, and project a continued strong growth during Q4. We have made some minor forecast adjustments due to the continued improved marketing efficiency and raise our Base-case valuation slightly. We continue to view MRG as attractively valued.
Read more and download the research update: http://bit.ly/2OgKWer
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/